from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1495/mazF4

LFCtreatmentdescriptionclass of inhibitor

-0.291

Amikacinug/mL Amikacintranslation

0.269

Cap5-10ug/mL Capreomycintranslation

0.364

Rox10-50 ug/mL Roxithromycintranslation

-0.136

SM2-5 ug/mL Streptomycintranslation

1.139

Tet5-10 ug/mL Tetracyclinetranslation

0.434

Rif0.2-5ug/mL Rifampicintranscription

-0.155

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.907

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.405

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.612

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.180

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.046

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

2.449

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.291

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.020

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.728

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.711

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.596

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.876

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.599

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

3.315

KCN5-20 ug/mL Potassium cyaniderespiration

-0.689

NaN30.2-2 mM Sodium aziderespiration

-0.220

Nigericin50 uM Nigericinrespiration

-0.196

TRC10-150 ug/mL Triclosanrespiration

-0.382

TRZ10-25 ug/mL Thioridazinerespiration

1.092

Valinomycin0.5-10 uM Valinomycinrespiration

0.318

ZnSO42 mM ZnSO4respiration

-0.223

menadione6-10 ug/mL Menadionerespiration

-0.445

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.084

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.397

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.306

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.237

NRP_1Non-replicating persistence stage 1dosRassociated

-0.028

Amp0.2mg/mL AmpicillincellWall

0.246

Cephalexin20-100 ug/mL CephalexincellWall

0.363

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.054

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.498

EMB10-20 ug/mL EthambutolcellWall

0.981

Eta12-40 ug/mL EthionamidecellWall

1.279

INH0.2-0.4 ug/mL IsoniazidcellWall

0.039

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.619

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.504

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.607

BZA0.12 mg/mL BenzamidearomaticAmides

0.111

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.084

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.761

H2O24 mM hydrogen peroxideDNAdamaging

0.119

Levo10 ug/mL LevofloxacinDNAdamaging

-0.495

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.550

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.632

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.398

UVUV-irradiationDNAdamaging

0.408

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.767

Antimycin12.5-50 ug/mL Antimycin A?

-0.491

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.638

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.156

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.723

PA8240.2-2 ug/mL PA-824?

1.487

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.346

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.543

Verapamil50 uM Verapamil?

-0.179

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.580

methoxatin10-20 ug/mL Methoxatin?